Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells
Giovanna Carrà, Antonio Cartellà, Beatrice Maffeo, Alessandro Morotti Department Of Clinical And Biological Sciences, University Of Turin, Orbassano 10043, ItalyCorrespondence: Alessandro MorottiDepartment Of Clinical And Biological Sciences, University Of Turin, Regione Gonzol...
Guardado en:
Autores principales: | Carrà G, Cartellà A, Maffeo B, Morotti A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d6b035faa8974ec89b243aab7d01bf27 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives
por: Anagnostou T, et al.
Publicado: (2017) -
Efficacy and Safety Profile of Ivosidenib in the Management of Patients with Acute Myeloid Leukemia (AML): An Update on the Emerging Evidence
por: Stemer G, et al.
Publicado: (2021) -
The first case of acute myeloid leukaemia/myeloid sarcoma with cytokeratin expression on blasts diagnosed on urine specimen
por: Claire Comerford, et al.
Publicado: (2021) -
PONATINIB EXPERIENCE IN A PEDIATRIC CHRONIC MYELOID LEUKEMIA PATIENT
por: Serap Karaman, et al.
Publicado: (2021) -
Imatinib in the treatment of chronic myeloid leukemia: current perspectives on optimal dose
por: Waclaw J, et al.
Publicado: (2015)